glp 1 drug history The transformative breakthroughs in GLP-1 research recognized by the 2024 Lasker~DeBakey award | Current Medicine Upgrading from Overweight: The Effects
Description
Refs, references
Journal of Clinical Endocrinology and Metabolism 2513171324
( Epub 20231228 )
Eriksson, R
Semaglutide could ultimately be a valuable pharmacological alternative or add-on to these medications, however, more studies are needed to determine the efficacy of this drug, as well as its safety in people with average and below average BMI for whom weight loss could cause medical problems
Then came Wegovy, a high-dose version officially marketed as an obesity treatment
